drugset / Trial / NCT01756183

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

NCT01756183 ↗

Phase 2 Unknown 60 enrolled Zhejiang Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

Exploratory the S-1 + Paclitaxel Chemotherapy for Creating the Operation Chance in the Patients with Unresectable Gastric Cancer

Timeline

Start
2011-09
Primary completion
2013-09
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 150 mg/m2 Intravenous
Subject S-1 Small molecule 60 mg —

Indications

No indication recorded.